{"id":15141,"date":"2015-07-23T12:24:11","date_gmt":"2015-07-23T11:24:11","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=15141"},"modified":"2015-07-23T12:24:11","modified_gmt":"2015-07-23T11:24:11","slug":"circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/","title":{"rendered":"Circular Farmac\u00e9utica: tratamiento de la queratosis act\u00ednica, estr\u00e9s y alimentaci\u00f3n, y un nuevo f\u00e1rmaco para el tratamiento de la dependencia alcoh\u00f3lica"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/07\/circular73-2.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-15142 alignleft\" alt=\"circular73-2\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/07\/circular73-2.jpg\" width=\"202\" height=\"264\" \/><\/a>El <a href=\"http:\/\/www.cofb.org\/es\/web\/guest\/circular-farmaceutica\/\" target=\"_blank\" rel=\"noopener\">nuevo n\u00famero de la revista cient\u00edfica Circular Farmac\u00e9utica<\/a> publica en su secci\u00f3n de Farmacoterapia los principales cambios en el documento de consenso GeSIDA 2015; analiza Nalfemeno, un nuevo f\u00e1rmaco para el tratamiento de la dependencia alcoh\u00f3lica, y estudia el tratamiento de la queratosis act\u00ednica y otros c\u00e1nceres de piel no melanomas. En el apartado de alimentaci\u00f3n y nutrici\u00f3n tambi\u00e9n encontrar\u00e1 un art\u00edculo sobre estr\u00e9s y nutrici\u00f3n.<\/p>\n<p>\u00c9ste es el contenido de la nueva publicaci\u00f3n (segundo trimestre 2015, vol. 73, n\u00fam. 2):<\/p>\n<ul>\n<li>Editorial: T. Casas\u00edn<\/li>\n<li>Farmacoterapia: Principales cambios en el documento de consenso GeSIDA 2015 \/ Nalfemeno: un nuevo f\u00e1rmaco para el tratamiento de la dependencia alcoh\u00f3lica \/ Tratamiento de la queratosis act\u00ednica y otros c\u00e1nceres de piel no melanomas<\/li>\n<li>Alimentaci\u00f3n y nutrici\u00f3n: Estr\u00e9s y alimentaci\u00f3n<\/li>\n<li>Innovadores<\/li>\n<li>Vademecum Cultural<\/li>\n<\/ul>\n<p><a href=\"http:\/\/www.cofb.org\/es\/web\/guest\/circular-farmaceutica\/\" target=\"_blank\" rel=\"noopener\">Ver n\u00fameros anteriores de Circular Farmac\u00e9utica<\/a> (v\u00eda <a href=\"http:\/\/www.cofb.org\/es\/\">www.cofb.org<\/a>)<\/p>","protected":false},"excerpt":{"rendered":"<p>El nuevo n\u00famero de la revista cient\u00edfica Circular Farmac\u00e9utica publica en su secci\u00f3n de Farmacoterapia los principales cambios en el documento de consenso GeSIDA 2015; analiza Nalfemeno, un nuevo f\u00e1rmaco para el tratamiento de la dependencia alcoh\u00f3lica, y estudia el tratamiento de la queratosis act\u00ednica y otros c\u00e1nceres de [\u2026]<\/p>","protected":false},"author":1,"featured_media":15152,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[16,2224,54,2149,2225],"class_list":["post-15141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-alimentacio-i-nutricio","tag-estres-i-alimentacio","tag-farmacs","tag-publicacions","tag-queratosis-actinica"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El nou n\u00famero de la revista cient\u00edfica Circular Farmac\u00e8utica publica a la seva secci\u00f3 de Farmacoter\u00e0pia els principals canvis en el document de consens GeSIDA 2015; analitza Nalfem\u00e8, un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica, i estudia el tractament de la queratosis act\u00ednica i altres c\u00e0ncers de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-07-23T11:24:11+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica\",\"datePublished\":\"2015-07-23T11:24:11+00:00\",\"dateModified\":\"2015-07-23T11:24:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\"},\"wordCount\":181,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Alimentaci\u00f3 i nutrici\u00f3\",\"estr\u00e8s i alimentaci\u00f3\",\"f\u00e0rmacs\",\"Publicacions\",\"queratosis act\u00ednica\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\",\"name\":\"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-07-23T11:24:11+00:00\",\"dateModified\":\"2015-07-23T11:24:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/","og_locale":"es_ES","og_type":"article","og_title":"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El nou n\u00famero de la revista cient\u00edfica Circular Farmac\u00e8utica publica a la seva secci\u00f3 de Farmacoter\u00e0pia els principals canvis en el document de consens GeSIDA 2015; analitza Nalfem\u00e8, un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica, i estudia el tractament de la queratosis act\u00ednica i altres c\u00e0ncers de [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-07-23T11:24:11+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica","datePublished":"2015-07-23T11:24:11+00:00","dateModified":"2015-07-23T11:24:11+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/"},"wordCount":181,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage"},"thumbnailUrl":"","keywords":["Alimentaci\u00f3 i nutrici\u00f3","estr\u00e8s i alimentaci\u00f3","f\u00e0rmacs","Publicacions","queratosis act\u00ednica"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/","url":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/","name":"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-07-23T11:24:11+00:00","dateModified":"2015-07-23T11:24:11+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/07\/23\/circular-farmaceutica-tractament-de-la-queratosis-actinica-estres-i-alimentacio-i-un-nou-farmac-per-al-tractament-de-la-dependencia-alcoholica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Circular Farmac\u00e9utica: tractament de la queratosis act\u00ednica, estr\u00e8s i alimentaci\u00f3, i un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El nou n\u00famero de la revista cient\u00edfica Circular Farmac\u00e8utica publica a la seva secci\u00f3 de Farmacoter\u00e0pia els principals canvis en el document de consens GeSIDA 2015; analitza Nalfem\u00e8, un nou f\u00e0rmac per al tractament de la depend\u00e8ncia alcoh\u00f2lica, i estudia el tractament de la queratosis act\u00ednica i altres c\u00e0ncers de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/15141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=15141"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/15141\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=15141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=15141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=15141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}